Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127100) titled 'Analysis of the Current Situation of Diagnosis and Treatment of Inflammatory Breast Cancer in China, Exploration of New Therapies and Development of New Targets: A Special Disease Cohort Study' on June 24.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: The Fourth Hospital of Hebei Medical University
Condition:
Breast cancer
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2024-10-23
Target Sample Size: Treatment group:400;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=313107
Published by HT Digital Cont...